Article
Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study
Fecha
2013Registro en:
LUETKEMEYER, Anne F. et al. Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study. Clinical infectious diseases, v. 57, n. 4, p. 586-593, 2013.
1058-4838
10.1093/cid/cit246
Autor
Luetkemeyer, Anne F.
Rosenkranz, Susan L.
Lu, Darlene
Marzan, Florence
Ive, Prudence
Hogg, Evelyn
Swindells, Susan
Benson, Constance A.
Grinsztejn, Beatriz
Sanne, Ian M.
Havlir, Diane V.
Aweeka, Francesca
Adult AIDS Clinical Trials Group A5221 Study Team